High-resolution esophageal manometry (HREM) is a diagnostic tool to evaluate esophageal motility patterns. HREM measures intraluminal pressure activity of the esophagus, providing contractile patterns of the body of the esophagus as well as comments on lower esophageal sphincter activity. In this webinar, we will discuss how the procedure is performed, which patient population would benefit from this procedure and what symptoms it is indicated for, and lastly how to incorporate the new Chicago 4.0 protocol guidelines and what diagnostic improvements it provides.
High-resolution anorectal manometry (HRAM) is a diagnostic tool to evaluate anorectal motility patterns. HRAM measures the pressure of the muscle contractions of the anus, providing contractile and relaxation patterns, the sensitivity of the rectum, and the reflexes that are required for normal defecation. In this webinar, we will discuss how the procedure is performed, which patient populations would benefit from this procedure and what symptoms it is indicated for, and lastly how to incorporate the London protocol guidelines and what diagnostic improvements it provides.
This webinar will involve an introduction to Chicago classification version 4.0, and then demonstrate a real-time study marking and analysis of an esophageal high-resolution manometry (HRM) study using the Chicago Classification version 4.0. Components of marking and analysis will include landmark identification, swallowing metrics, and how to use the classification algorithm.
This interactive presentation is focused on endoscopic ultrasound (EUS) and its relative growth as a technology, its current and expanding applications, and highlights state-of-the-art EUS guided therapeutic interventions. The lecture is intended to provide both perspective on opportunities to expand EUS practice through an understanding of its role in multidisciplinary care and various disease state applications. Additionally, endohepatology and EUS guided novel therapeutic interventions will be demonstrated through case-based videos.
Inflammatory Bowel Disease (also known as IBD) is an autoimmune condition requiring coordinated care from the medical team. The landscape for IBD treatment is constantly changing and expanding. This presentation will focus on the role of the nurse caring for a patient with IBD. It is important to understand the pathophysiology of IBD, in order to educate our patients. Additionally, we will discuss the various diagnostic methods used to workup and monitor IBD patients. We will also cover various therapeutic solutions for our IBD patients and discuss the nurse-patient relationship in IBD care.
Small bowel bleeding (SBB) is suspected in patients with overt and occult gastrointestinal bleeding that is unexplained after initial upper GI endoscopy and colonoscopy. A variety of technologies are currently available for the diagnosis of bleeding sources in the deep small bowel. This webinar will review these technologies and recommendations their use with specific references to current published literature.
Given the high prevalence of gastroesophageal reflux disease (GERD) and the various complications which can result from inadequate treatment, it is important for practitioners to have a proper understanding of the current approach to its diagnosis and management. This presentation will review the pathophysiology of GERD and associated symptoms. Traditional and novel technologies to diagnose GERD and Barrett’s esophagus will be discussed, along with the importance of pH monitoring as both a diagnostic and therapeutic modality. Lastly, the range of treatment options for chronic reflux will be discussed.
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract characterized by inflammation at any point from the mouth to the rectum. This webinar will discuss the pathways to diagnosis, treatment, and monitoring of both suspected and known Crohn’s disease of the small bowel and colon, utilizing society guidelines and new evidence-based clinical data. Steps to determining a diagnosis, staging, diagnostic testing modalities, treatment pathways and evaluation of mucosal healing in response to treatment using scoring test and imaging modalities will be covered.
Given the high prevalence of gastroesophageal reflux disease (GERD) and the various complications which can result from inadequate treatment, it is important for practitioners to have a proper understanding of the current approach to its diagnosis and management. This webinar presented by a leading expert in GI disorders, will provide an update of the current diagnostic paradigms for GERD including, esophageal pH testing and interpretation, motility testing, and patient management.
Microwave ablation (MWA) of hepatic malignancies is an effective treatment strategy for patients unable to tolerate definitive resection or transplantation. The laparoscopic approach is an underutilized technique and prognostic factors of survival in this setting are not well characterized. The aim of this webinar will be to present optimal approaches and techniques to consider regarding, patient selection, tumor location, and other prognostic factors for MWA.
Esophageal high-resolution manometry (HRM) is the current state-of-the-art diagnostic tool to evaluate esophageal motility patterns. HRM measures intraluminal pressure activity in the gastrointestinal tract using a series of closely spaced pressure sensors. In this webinar, we will discuss how the procedure is performed, which patient population would benefit from this procedure, how to interpret the results and lastly, the clinical applicability of the test results.
Barrett’s esophagus (BE) is a common, costly disease associated with a low, but real, risk of esophageal adenocarcinoma. Despite the common nature of this condition, care for patients with BE is inconsistent and often suboptimal, with wide variations reported. In this presentation, we will discuss the best management of BE patients, with a focus on new data in 3 areas: Chemoprevention, non-endoscopic screening, and endoscopic therapy of BE.